EXACT SCIENCES 2023 SUSTAINABILITY ACCOUNTING STANDARDS BOARD (SASB) INDEX
These tables provide data and information using the SASB Health Care Delivery standard, which we believe best represents the nature of Exact Sciences' operations. We also include indicators from the Biotechnology and Pharmaceuticals standard. The data represents full-year 2023 performance.
Category | Code | Accounting Metric | Information | |
Energy | (1) Total energy consumed, (2) percentage grid electricity, | (1) | 32,154,754 kWh of electricity, 767,784 therms of natural gas | |
HC-DY-130a.1 | (2) | 59% | ||
Management | (3) percentage renewable | |||
(3) | 0% | |||
39 U.S. tons of medical waste | ||||
Total amount of medical waste, percentage (a) incinerated, | (a) | 31% | ||
HC-DY-150a.1 | (b) | 0% | ||
(b) recycled or treated, and (c) landfilled | (c) | 69% | ||
For details, see: Waste Management in our 2023 ESG Report | ||||
(1) 101 U.S. tons of hazardous waste | ||||
Waste | (a) | 81% | ||
Management | (b) | 11% | ||
Total amount of (1) hazardous and (2) nonhazardous | (c) | 8% | ||
HC-DY-150a.2 | ||||
pharmaceutical waste, percentage | (2) 4,818 U.S. tons of nonhazardous waste | |||
(a) incinerated, (b) recycled or treated, and (c) landfilled | (a) | 7% | ||
(b) | 45% | |||
(c) | 47% | |||
For details, see: Waste Management in our 2023 ESG Report | ||||
Percentage of patient records that are Electronic Health | Not reported | |||
HC-DY-230a.1 | For details, see: Cybersecurity, Privacy & Data Protection in our 2023 ESG Report | |||
Records (EHR) that meet "meaningful use" requirements | ||||
Patient Privacy & | ||||
Electronic Health | We have technical, administrative, and physical safeguards in place to help protect | |||
Records | Description of policies and practices to secure customers' | |||
HC-DY-230a.2 | against unauthorized access to, use, or disclosure of patient and employee | |||
protected health information (PHI) records and other | information and data we collect and store. | |||
personally identifiable information (PII) | For details, see: Cybersecurity, Privacy & Data Protection in our 2023 ESG Report | |||
1
EXACT SCIENCES 2023 SUSTAINABILITY ACCOUNTING STANDARDS BOARD (SASB) INDEX
Category | Code | Accounting Metric | Information |
(1) Number of data breaches, (2) percentage | Not reported | ||
Patient Privacy & | HC-DY-230a.3 | involving (a) personally identifiable information (PII) only and (b) | |
protected health information (PHI), (3) number of customers | For details, see: Cybersecurity, Privacy & Data Protection in our 2023 ESG Report | ||
Electronic Health | affected in each category, (a) PII only and (b) PHI2 | ||
Records | |||
HC-DY-230a.4 | Total amount of monetary losses as a result of legal | Material legal, regulatory, and monetary issues are disclosed in our annual 10-K and | |
proceedings associated with data security and privacy | quarterly 10-Qs. | ||
Exact Sciences takes every viable step to make testing available, accessible, and | |||
Discussion of strategy to manage the mix of patient insurance | affordable, and we offer financial assistance programs for eligible patients with | ||
HC-DY-240a.1 | financial hardship. | ||
Accessfor Low- | status | ||
For details, see: Access to Tests in our 2023 ESG Report | |||
Income Patients | |||
HC-DY-240a.2 | Amount of Medicare Disproportionate Share Hospital (DSH) | Not applicable - Exact Sciences provides laboratory testing services | |
adjustment payments received | |||
HC-DY-250a.1 | Average Hospital Value-Based Purchasing Total Performance | Not applicable - Exact Sciences provides laboratory testing services | |
Score and domain score, across all facilities | |||
HC-DY-250a.2 | Number of Serious Reportable Events (SREs) as defined by the | Not reported | |
National Quality Forum (NQF) | |||
Quality of Care & | |||
Patient | HC-DY-250a.3 | Hospital-Acquired Condition (HAC) Score per Hospital | Not applicable - Exact Sciences provides laboratory testing services |
Satisfaction | |||
HC-DY-250a.4 | Excess readmission ratio per hospital | Not applicable - Exact Sciences provides laboratory testing services | |
HC-DY-250a.5 | Magnitude of readmissions payment adjustment as part of the | Not applicable - Exact Sciences provides laboratory testing services | |
Hospital Readmissions Reduction Program (HRRP) | |||
HC-DY-260a.1 | Description of policies and practices to manage the number of | Not applicable - Exact Sciences provides laboratory testing services | |
Management of | prescriptions issued for controlled substances | ||
Controlled | |||
Percentage of controlled substance prescriptions written for | |||
Substances | HC-DY-260a.2 | Not applicable - Exact Sciences provides laboratory testing services | |
which a prescription drug monitoring program (PDMP) database | |||
was queried | |||
Pricing & Billing | HC-DY-270a.1 | Description of policies or initiatives to ensure that patients are | Not applicable - Exact Sciences provides laboratory testing servicesĂ |
Transparency | adequately informed about price before undergoing a procedure | For details, see: Access to Health Care in our 2023 ESG Report | |
2
EXACT SCIENCES 2023 SUSTAINABILITY ACCOUNTING STANDARDS BOARD (SASB) INDEX
Category | Code | Accounting Metric | Information | |
We have a Patient Support Team providing informational resources to | ||||
Discussion of how pricing information for services is made | patients who have questions about our products and services, including | |||
HC-DY-270a.2 | insurance coverage | |||
publicly available | ||||
Pricing & Billing | ||||
For details, see: Access to Tests in our 2023 ESG Report | ||||
Transparency | ||||
Number of the entity's 25 most common services for which | ||||
HC-DY-270a.3 | pricing information is publicly available, percentage of total | Not reported | ||
services performed (by volume) that these represent | ||||
Employee Health & | HC-DY-320a.1 | (1) Total recordable incident rate (TRIR) and (2) days away, | (1) | 0.49 per 200,000 hours worked |
Safety | restricted, or transferred (DART) Rate | (2) | 0.33 | |
(1) Voluntary and (2) involuntary turnover rate for: (a) | (a) Not applicable - Exact Sciences does not employ physicians. | |||
(b) Not applicable - Exact Sciences does not employ health care | ||||
HC-DY-330a.1 | physicians, (b) non-physician health care practitioners, and (c) all | |||
other employees | practitioners. | |||
Employee | (c) Voluntary: 8.4%, involuntary: 4.6% | |||
Recruitment, | We are committed to providing safe and healthy work environments for | |||
Development & | our employees, where equal opportunity and diversity in thought, | |||
Retention | HC-DY-330a.2 | Description of talent recruitment and retention efforts for | experience, perspective, and background are commonplace. Note, we do | |
HC-BP-330a.1 | health care practitioners | not employ health care practitioners. | ||
For details, see: Human Capital in our 2023 ESG Report | ||||
Description of policies and practices to address: (1) the physical | ||||
HC-DY-450a.1 | risks due to an increased frequency and intensity of extreme | For details, see: TCFD Index in our 2023 ESG Report | ||
Climate Change | weather events and (2) changes in the morbidity and mortality | |||
Impacts on | rates of illnesses and diseases, associated with climate change | |||
Human Health & | ||||
Infrastructure | Percentage of health care facilities that comply with the Centers | |||
HC-DY-450a.2 | for Medicare and Medicaid Services (CMS) Emergency | Not applicable - Exact Sciences provides laboratory testing services. | ||
Preparedness Rule | ||||
Fraud & | Total amount of monetary losses as a result of legal | Material legal and regulatory issues are disclosed in our annual 10-K | ||
Unnecessary | HC-DY-510a.1 | proceedings associated with Medicare and Medicaid fraud | ||
and quarterly 10-Qs. | ||||
Procedures | under the False Claims Act | |||
3
EXACT SCIENCES 2023 SUSTAINABILITY ACCOUNTING STANDARDS BOARD (SASB) INDEX
Category
Code | Accounting Metric |
Information
Employees involved in sales and marketing receive regular compliance training on the | ||||
laws, regulations, and codes that govern interactions with physicians and other | ||||
HC-BP-270a.2 | Description of code of ethics governing promotion of off-label | customers, on the promotion of our products, and on our Code of Business Conduct and | ||
use of products | Ethics. | |||
Ethics | ||||
For details, see Business Ethics in our 2023 ESG Report | ||||
HC-BP-510a.2 | Description of code of ethics governing interactions with health | See ourCode of Conduct on Interactions with Health Care Professionals | ||
care professionals | ||||
We design and conduct all clinical studies in accordance with the general principles set | ||||
forth in the International Ethical Guidelines for Biomedical Research Involving Human | ||||
Safety of Clinical | HC-BP-210a.1 | Discussion, by world region, of management process for ensuring | Subjects (by the Council for International Organizations for Medical Sciences), USFDA | |
Trial Participants | quality and patient safety during clinical trials | Title 21 CRF §11, 50, 54, 56, 812, & 814, the Declaration of Helsinki (World Medical | ||
Association), and ICH GCP E6. | ||||
For details, see: Clinical Research Programs & Standards in our 2023 ESG Report | ||||
HC-DY-000.A | Number of (1) facilities and (2) beds, by type | Not applicable - Exact Sciences provides laboratory testing services. | ||
HC-DY-000.B | Number of (1) inpatient admissions and (2) outpatient visits | Not applicable - Exact Sciences provides laboratory testing services. | ||
As of 2023, we screened more than 14 million patients with Cologuard and tested | ||||
Activity Metrics | HC-BP-000.A | Number of patients treated | nearly 1.3 million patients with Oncotype. | |
For details, see: Taking Care of the People We Serve in our 2023 ESG Report | ||||
Not applicable - Exact Sciences provides laboratory testing services. | ||||
HC-BP-000.B | Number of drugs (1) in portfolio and (2) in research and | (1) | See Our Testson our website to learn more. | |
development (Phases 1-3) | ||||
(2) | See Our Pipeline & Dataon our website to learn more. | |||
4
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
EXACT Sciences Corporation published this content on 02 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 May 2024 11:52:25 UTC.